Publications in 2020
Vazquez-Borrego MC, L-Lopez F, Galvez-Moreno MA, Fuentes-Fayos AC, Venegas-Moreno E, Herrera-Martinez AD, Blanco-Acevedo C, Solivera J, Landsman T, Gahete MD, Soto-Moreno A, Culler MD, Castano JP, Luque RM. A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells. NEUROENDOCRINOLOGY. 2020. 110 (1-2):70-82 DOI: 10.1159/000500812
IF: 4,271 Q: 1
Lopez-Andreu M, Cabello MDN, Sanchez-Sanchez R, Rodriguez-Portillo JM, Cabrera SS. A patient with recurrent ventricular fibrillation and renal failure. KIDNEY INTERNATIONAL. 2020. 98 (3):795-796 DOI: 10.1016/j.kint.2020.03.013
IF: 8,945 Q: 1 D: 1
Segura JS, Rosa JV, Gomez EG, Cabello MDN, Garcia JR, Benot AR, Garcia JER, Tapia MJR, Hernandez JPC. A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant Surgical Aspects and Outcomes. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 2020. 18 (2):149-152 DOI: 10.6002/ect.2019.0372
IF: 0,852 Q: 4
Vazquez-Borrego MC, Gupta V, Ibanez-Costa A, Gahete MD, Venegas-Moreno E, Toledano-Delgado A, Cano DA, Blanco-Acevedo C, Ortega-Salas R, Japon MA, Barrera-Martin A, Vasiljevic A, Hill J, Zhang SW, Halem H, Solivera J, Raverot G, Galvez MA, Soto-Moreno A, . A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors. CLINICAL CANCER RESEARCH. 2020. 26 (4):957-969 DOI: 10.1158/1078-0432.CCR-19-2154
IF: 10,107 Q: 1
Reyes O, Perez E, Luque RM, Castano J, Ventura S. A supervised machine learning-based methodology for analyzing dysregulation in splicing machinery: An application in cancer diagnosis. ARTIFICIAL INTELLIGENCE IN MEDICINE. 2020. 108 ():- DOI: 10.1016/j.artmed.2020.101950
IF: 4,383 Q: 1
Gutierrez-Mariscal FM, Garcia-Rios A, Gomez-Luna P, Fernandez-Gandara C, Cardelo MP, de la Cruz-Ares S, Rodriguez-Cantalejo F, Luque RM, Leon-Acuna A, Delgado-Lista J, Perez-Martinez P, Yubero-Serrano EM, Lopez-Miranda J. Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study). BMC GERIATRICS. 2020. 20 (1):- DOI: 10.1186/s12877-020-01544-5
IF: 3,077 Q: 1
Gatto F, Perez-Rivas LG, Olarescu NC, Khandeva P, Chachlaki K, Trivellin G, Gahete MD, Cuny T. Diagnosis and Treatment of Parasellar Lesions. NEUROENDOCRINOLOGY. 2020. 110 (44113):728-739 DOI: 10.1159/000506905
IF: 4,271 Q: 1
del Rio-Moreno M, Luque RM, Rangel-Zuniga OA, Alors-Perez E, Alcala-Diaz JF, Roncero-Ramos I, Camargo A, Gahete MD, Lopez-Miranda J, Castano JP. Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study. NUTRIENTS. 2020. 12 (11):- DOI: 10.3390/nu12113528
IF: 4,546 Q: 1
Garcia-Martinez A, Fuentes-Fayos AC, Fajardo C, Lamas C, Camara R, Lopez-Munoz B, Aranda I, Luque RM, Pico A. Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (6):- DOI: 10.3390/jcm9061838
IF: 3,303 Q: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gomez-Gomez E, Fuentes-Fayos AC, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Pedraza-Arevalo S, Gonzalez-Serrano T, Reyes O, Martinez-Lopez A, Sanchez-Sanchez R, Ventura S, Yubero-Serrano EM, R. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBIOMEDICINE. 2020. 51 ():- DOI: 10.1016/j.ebiom.2019.11.008
IF: 5,736 Q: 1
Sanchez-Garrido MA, Ruiz-Pino F, Pozo-Salas AI, Castellano JM, Vazquez MJ, Luque RM, Tena-Sempere M. Early overnutrition sensitizes the growth hormone axis to the impact of diet-induced obesity via sex-divergent mechanisms. SCIENTIFIC REPORTS. 2020. 10 (1):- DOI: 10.1038/s41598-020-70898-y
IF: 3,998 Q: 1
Puche-Sanz I, Sabio-Bonilla A, Sanchez-Conde V, Jimenez-Dominguez AC, Tamayo-Gomez A, Vila-Brana P, Vazquez-Alonso F, Rivas JG, Gomez-Gomez E, Campos-Juanatey F, Rodriguez JGO, Flores-Martin J, Moreno-Jimenez J, Cozar-Olmo JM. Emergency surgery during COVID-19 pandemia. ARCHIVOS ESPANOLES DE UROLOGIA. 2020. 73 (5):353-359
IF: 0,395 Q: 4
Quintana-Navarro GM, Alcala-Diaz JF, Lopez-Moreno J, Perez-Corral I, Leon-Acuna A, Torres-Pena JD, Rangel-Zuniga OA, de Larriva APA, Corina A, Camargo A, Yubero-Serrano EM, Rodriguez-Cantalejo F, Garcia-Rios A, Luque RM, Ordovas JM, Perez-Martinez P, Lope. Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial. EUROPEAN JOURNAL OF NUTRITION. 2020. 59 (5):2099-2110 DOI: 10.1007/s00394-019-02059-5
IF: 4,664 Q: 1
Pozuelo-Sanchez I, Villasanta-Gonzalez A, Alcala-Diaz JF, Vals-Delgado C, Leon-Acuna A, Gonzalez-Requero A, Yubero-Serrano EM, Luque RM, Caballero-Villarraso J, Quesada I, Ordovas JM, Perez-Martinez P, Roncero-Ramos I, Lopez-Miranda J. Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. 2020. 68 (5):1266-1275 DOI: 10.1021/acs.jafc.9b06801
IF: 4,192 Q: 1 D: 1
Roncero-Ramos I, Alcala-Diaz JF, Rangel-Zuniga OA, Gomez-Delgado F, Jimenez-Lucena R, Garcia-Rios A, Vals-Delgado C, Romero-Baldonado C, Luque RM, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study. CLINICAL NUTRITION. 2020. 39 (2):492-500 DOI: 10.1016/j.clnu.2019.02.027
IF: 6,36 Q: 1
Flores-Martinez A, Venegas-Moreno E, Dios E, Remon-Ruiz P, Gros-Herguido N, Vazquez-Borrego MC, Madrazo-Atutxa A, Japon MA, Kaen A, Cardenas-Valdepenas E, Roldan F, Castano JP, Luque RM, Cano DA, Soto-Moreno A. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (9):- DOI: 10.3390/jcm9093052
IF: 3,303 Q: 1
Gutierrez-Mariscal FM, Cardelo MP, de la Cruz S, Alcala-Diaz JF, Roncero-Ramos I, Guler I, Vals-Delgado C, Lopez-Moreno A, Luque RM, Delgado-Lista J, Perez-Martinez P, Yubero-Serrano EM, Lopez-Miranda J. Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. MOLECULAR NUTRITION & FOOD RESEARCH. 2021. 65 (1):- DOI: 10.1002/mnfr.201901290
IF: 5,309 Q: 1 D: 1
Fuentes-Fayos AC, Vazquez-Borrego MC, Jimenez-Vacas JM, Bejarano L, Pedraza-Arevalo S, L-Lopez F, Blanco-Acevedo C, Sanchez-Sanchez R, Reyes O, Ventura S, Solivera J, Breunig JJ, Blasco MA, Gahete MD, Castano JP, Luque RM. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. BRAIN. 2020. 143 ():3273-3293 DOI: 10.1093/brain/awaa273
IF: 11,337 Q: 1 D: 1
Vazquez-Borrego MC, Fuentes-Fayos AC, Herrera-Martinez AD, Venegas-Moreno E, L-Lopez F, Fanciulli A, Moreno-Moreno P, Alhambra-Exposito MR, Barrera-Martin A, Dios E, Blanco-Acevedo C, Solivera J, Granata R, Kineman RD, Gahete MD, Soto-Moreno A, Galvez-Moreno MA, Castano JP, Luque RM. Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors. NEUROENDOCRINOLOGY. 2020. 110 (44176):1028-1041 DOI: 10.1159/000505923
IF: 4,271 Q: 1
Saez-Martinez P, Jimenez-Vacas JM, Leon-Gonzalez AJ, Herrero-Aguayo V, Hidalgo AJM, Gomez-Gomez E, Sanchez-Sanchez R, Requena-Tapia MJ, Castano JP, Gahete MD, Luque RM. Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2020. 9 (6):- DOI: 10.3390/jcm9061703
IF: 3,303 Q: 1"
Publications in 2019
Jiménez-Vacas JM, Gómez-Gómez E, Montero-Hidalgo AJ, Herrero-Aguayo V, L-López F, Sánchez-Sánchez R, Guler I, Blanca A, Méndez-Vidal MJ, Carrasco J, Lopez-Miranda J, Requena-Tapia MJ, Castaño JP, Gahete MD, Luque RM. Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2019 Nov 22;8(12). pii: E2056. doi: 10.3390/jcm8122056.
IF: 5,583 Q: 1 D: 1
Del Rio-Moreno M, Alors-Perez E, De Souza PB, Prados-Gonzalez ME, Castano JP, Luque RM, Gahete MD; Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types. TRANSLATIONAL RESEARCH. 2019 Sep;211:147-160. doi: 10.1016/j.trsl.2019.02.013.
IF: 4,915 Q: 1 D: 1
Jimenez-Vacas JM, Herrero-Aguayo V, Gomez-Gomez E, Leon-Gonzalez AJ, Saez-Martinez P, Alors-Perez E, Fuentes-Fayos AC, Martinez-Lopez A, Sanchez-Sanchez R, Gonzalez-Serrano T, Lopez-Ruiz DJ, Requena-Tapia MJ, Castano JP, Gahete MD, Luque RM; Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. TRANSLATIONAL RESEARCH. 212. (89-103). DOI: 10.1016/j.trsl.2019.07.001.
IF: 4,915 Q: 1 D: 1
Vazquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cortes E, Dios E, Moreno-Moreno P, Madrazo-Atutxa A, Remon P, Solivera J, Wildemberg LE, Kasuki L, Lopez-Fernandez JM, Gadelha MR, Galvez-Moreno MA, Soto-Moreno A, Gahete MD, Castano JP, Luque RM; Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features. CANCERS. 2019 Sep 26;11(10). pii: E1439. doi: 10.3390/cancers11101439.
IF: 6,162 Q: 1
Gomez-Gomez, E; Jimenez-Vacas, JM; Pedraza-Arevalo, S; Lopez-Lopez, F; Herrero-Aguayo, V; Hormaechea-Agulla, D; Valero-Rosa, J; Ibanez-Costa, A; Leon-Gonzalez, AJ; Sanchez-Sanchez, R; Gonzalez-Serrano, T; Requena-Tapia, MJ; Castano, JP; Carrasco-Valiente, Gahete MD, Luque RM; Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer. JOURNAL OF CLINICAL MEDICINE. 2019 Sep 6;8(9). pii: E1400. doi: 10.3390/jcm8091400.
IF: 5,688 Q: 1 D: 1
Thomas PB, Seim I, Jeffery PL, Gahete MD, Maugham M, Crisp GJ, Stacey A, Shah ET, Walpole C, Whiteside EJ, Nelson CC, Herington AC, Luque RM, Veedu RN, Chopin LK. The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth. INTERNATIONAL JOURNAL OF ONCOLOGY. 2019 Dec;55(6):1223-1236. doi: 10.3892/ijo.2019.4891.
IF: 3,571 D: 1
Quintana-Navarro GM, Alcala-Diaz JF, Lopez-Moreno J, Perez-Corral I, Leon-Acuña A, Torres-Peña JD, Rangel-Zuñiga OA, Arenas de Larriva AP, Corina A, Camargo A, Yubero-Serrano EM, Rodriguez-Cantalejo F, Garcia-Rios A, Luque RM, Ordovas JM, Perez-Martinez P, Lopez-Miranda J, Delgado-Lista J. Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial. EUROPEAN JOURNAL OF NUTRITION. 2019 Jul 24. doi: 10.1007/s00394-019-02059-5.
IF: 4,449 D: 1
Hoa O, Lafont C, Fontanaud P, Guillou A, Kemkem Y, Kineman RD, Luque RM, Fiordelisio Coll T, Le Tissier P, Mollard P. Imaging and Manipulating Pituitary Function in the Awake Mouse. ENDOCRINOLOGY. 2019 Oct 1;160(10):2271-2281. doi: 10.1210/en.2019-00297.
IF: 3,800 D: 1
Herrera-Martínez AD, Pedraza-Arevalo S, L-López F, Gahete MD, Gálvez-Moreno MA, Castaño JP, Luque RM. Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?. THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Jan 1;104(1):57-73. doi: 10.1210/jc.2018-01455.
Q: 1
Remacha L, Pirman D, Mahoney CE, Coloma J, Calsina B, Curras-Freixes M, Leton R, Torres-Perez R, Richter S, Pita G, Herraez B, Cianchetta G, Honrado E, Maestre L, Urioste M, Aller J, Garcia-Uriarte O, Galvez MA, Luque RM, Lahera M, Moreno-Rengel C, Eisenh; Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas. AMERICAN JOURNAL OF HUMAN GENETICS. 2019 Apr 4;104(4):651-664. doi: 10.1016/j.ajhg.2019.02.017
IF: 9,924 D: 1
Olarescu NC, Perez-Rivas LG, Gatto F, Cuny T, Tichomirowa MA, Tamagno G, Gahete MD; Aggressive and Malignant Prolactinomas. NEUROENDOCRINOLOGY. 2019;109(1):57-69. doi: 10.1159/000497205.
IF: 6,804 D: 1
Biagetti B, Herance JR, Ferrer R, Aulinas A, Palomino-Schatzlein M, Mesa J, Castano JP, Luque RM, Simo R; Metabolic Fingerprint of Acromegaly and Its Potential Usefulness in Clinical Practice. JOURNAL OF CLINICAL MEDICINE. 2019 Sep 26;8(10). pii: E1549. doi: 10.3390/jcm8101549.
IF: 5,688 Q:1 D:1
Vazquez-Borrego MC, Fuentes-Fayos AC, Herrera-Martinez AD, L-Lopez F, Ibanez-Costa A, Moreno-Moreno P, Alhambra-Exposito MR, Barrera-Martin A, Blanco-Acevedo C, Dios E, Venegas-Moreno E, Solivera J, Gahete MD, Soto-Moreno A, Galvez-Moreno MA, Castano JP, Luque RM; Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Aug 1;104(8):3501-3513. doi: 10.1210/jc.2019-00056.
IF: 5,605 Q: 1
del Rio-Moreno M, Alors-Perez E, Gonzalez-Rubio S, Ferrin G, Reyes O, Rodriguez-Peralvarez M, Sanchez-Frias ME, Sanchez-Sanchez R, Ventura S, Lopez-Miranda J, Kineman RD, de la Mata M, Castano JP, Gahete MD, Luque RM; Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2019 Aug 1;104(8):3389-3402. doi: 10.1210/jc.2019-00021.
IF: 5,605 Q; 1
Herrera-Martinez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Moreno MAG, Luque RM, Castano JP, de Herder WW, Feelders RA; Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. DRUGS. 2019 Jan;79(1):21-42. doi: 10.1007/s40265-018-1033-0.
IF: 4,993 Q: 1
Herrera-Martinez AD, van den Dungen R, Dogan-Oruc F, van Koetsveld PM, Culler MD, de Herder WW, Luque RM, Feelders RA, Hofland LJ; Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors. ENDOCRINE-RELATED CANCER. 2019 Jun;26(6):585-599. doi: 10.1530/ERC-19-0086.
IF: 4,774 Q; 1
Frantzi M, Gomez EG, Pedregosa AB, Rosa JV, Latosinska A, Culig Z, Merseburger AS, Luque RM, Tapia MJR, Mischak H, Valiente JC; CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer. BRITISH JOURNAL OF CANCER. 2019 Jun;120(12):1120-1128. doi: 10.1038/s41416-019-0472-z.
IF: 5,416 Q: 1
Gomez-Gomez E, Carrasco-Valiente J, Campos-Hernandez JP, Blanca-Pedregosa AM, Jimenez-Vacas JM, Ruiz-Garcia J, Valero-Rosa J, Luque RM, Requena-Tapia MJ; Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019 Feb;23(2):934-942. doi: 10.1111/jcmm.13994.
IF: 4,658 Q: 1
Venegas-Moreno E, Flores-Martinez A, Dios E, Vazquez-Borrego MC, Ibanez-Costa A, Madrazo-Atutxa A, Japon MA, Castano JP, Luque RM, Cano DA, Soto-Moreno A; E-cadherin expression is associated with somatostatin analogue response in acromegaly. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.2019 May;23(5):3088-3096. doi: 10.1111/jcmm.13851.
IF: 4,658 Q: 1
Borque-Fernando A, Rubio-Briones J, Esteban LM, Dong Y, Calatrava A, Gomez-Ferrer A, Gomez-Gomez E, Fabra JMG, Rodriguez-Garcia N, Gonzalez PAL, Garcia-Rodriguez J, Rodrigo-Aliaga M, Herrera-Imbroda B, Soto-Villalba J, Martinez-Breijo S, Hernandez-Canas V; Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance. PROSTATE CANCER AND PROSTATIC DISEASES. 2019 Mar;22(1):84-90. doi: 10.1038/s41391-018-0074-5.
IF: 4,6 Q: 1
Leon-Acuna A, Torres-Pena JD, Alcala-Diaz JF, Vals-Delgado C, Roncero-Ramos I, Yubero-Serrano E, Tinahones FJ, Castro-Clerico M, Delgado-Lista J, Ordovas JM, Lopez-Miranda J, Perez-Martinez P; Lifestyle factors modulate postprandial hypertriglyceridemia: From the CORDIOPREV study. ATHEROSCLEROSIS. 2019 Nov;290:118-124. doi: 10.1016/j.atherosclerosis.2019.09.025
IF: 4,255 Q: 1
Coelho MCA, Vasquez ML, Wildemberg LE, Vazquez-Borrego MC, Bitana L, Camacho AHD, Silva D, Ogino LL, Ventura N, Sanchez-Sanchez R, Chimelli L, Kasuki L, Luque RM, Gadelha MR; Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles. SCIENTIFIC REPORTS. 2019 Feb 4;9(1):1122. doi: 10.1038/s41598-018-37692-3.
IF: 4,011 Q: 1
Gomez-Delgado F, Alcala-Diaz JF, Leon-Acuna A, Lopez-Moreno J, Delgado-Lista J, Gomez-Marin B, Roncero-Ramos I, Yubero-Serrano EM, Rangel-Zuniga OA, Vals-Delgado C, Luque RM, Ordovas JM, Lopez-Miranda J, Perez-Martinez P; Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2019 Aug;49(8):e13146. doi: 10.1111/eci.13146.
IF: 2,784 Q: 1
Soriano S, Castellano-Munoz M, Rafacho A, Alonso-Magdalena P, Marroqui L, Ruiz-Pino A, Bru-Tari E, Merino B, Irles E, Bello-Perez M, Iborra P, Villar-Pazos S, Vettorazzi JF, Montanya E, Luque RM, Nadal A, Quesada I; Cortistatin regulates glucose-induced electrical activity and insulin secretion in mouse pancreatic beta-cells. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2019 Jan 5;479:123-132. doi: 10.1016/j.mce.2018.09.009.
IF: 3,693 Q: 2
Blanca A, Sanchez-Gonzalez A, Requena MJ, Carrasco-Valiente J, Gomez-Gomez E, Cheng L, Cimadamore A, Montironi R, Lopez-Beltran A; Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer. APMIS. 2019 Aug;127(8):545-553. doi: 10.1111/apm.12973.
IF: 2,225 Q: 2
Fuentes-Fayos AC, Garcia-Martinez A, Herrera-Martinez AD, Jimenez-Vacas JM, Vazquez-Borrego MC, Castano JP, Pico A, Gahete MD, Luque RM; Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors. MINERVA ENDOCRINOLOGICA. 2019 Jun;44(2):109-128. doi: 10.23736/S0391-1977.19.02970-5.
IF: 1,817 Q: 4
Juárez-Soto A, Garín-Ferreira JM, Rodríguez-Fernández A, Tirado-Hospital JL, González-Serrano MT, Moreno-Jiménez J, Medina-López R, Baena-González V. Diagnosis of metastasis in castration-resistant prostate cancer patients: decision algorithm in imaging tests. ACTAS UROLOGICAS ESPANOLAS. 2019 Mar;43(2):55-61. doi: 10.1016/j.acuro.2018.05.011
IF: 1,136 D: 2
Gomez Gomez E, Salamanca Bustos JJ, Carrasco Valiente J, Fernandez Rueda JL, Blanca A, Valero Rosa J, Bravo Arrebola I, Marquez López J, Jimenez Vacas JM, Luque R, Requena Tapia MJ. Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL. BRITISH MEDICAL JOURNAL OPEN. 2019 Nov 12;9(11):e031032. doi: 10.1136/bmjopen-2019-031032.
IF: 2,376 D: 2
Gómez-Gómez E, Carrasco-Valiente J, Campos-Hernández JP, Blanca-Pedregosa AM, Jiménez-Vacas JM, Ruiz-García J, Valero-Rosa J, Luque RM, Requena-Tapia MJ. Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2019 Feb;23(2):934-942. doi: 10.1111/jcmm.13994.
IF: 4,658 Q: 1
Publications in 2018
Gahete MD, Del Rio-Moreno M, Camargo A, Alcala-Diaz JF, Alors-Perez E, Delgado-Lista J, Reyes O, Ventura S, Perez-Martínez P, Castaño JP, Lopez-Miranda J, Luque RM. Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study. EBioMedicine 2018, 3964(18)30479-1.
IF: 6.680 Q: 1 D: 1
Vázquez-Borrego MC, Fuentes-Fayos AC, Gahete MD, Castaño JP, Kineman RD, Luque RM. The pituitary gland is a novel major site of action of metformin in non-human primates: A potential path to expand and integrate its metabolic actions. Cell Physiol Biochem 2018, 49(4):1444-1459.
IF: 5.500 Q: 1 D: 1
Gómez-Gómez E, Jiménez-Vacas JM, Carrasco-Valiente J, Herrero-Aguayo V, Blanca-Pedregosa AM, León-González AJ, Valero-Rosa J, Fernández-Rueda JL, González-Serrano T, López-Miranda J, Gahete MD, Castaño JP, Requena-Tapia MJ, Luque RM. Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer. J Cell Mol Med 2018, 22(11):5688-5697.
IF: 4.658 Q: 1
Herrera-Martínez AD, Gahete MD, Sánchez-Sánchez R, Alors-Perez E, Pedraza-Arevalo S, Serrano-Blanch R, Martínez-Fuentes AJ, Gálvez-Moreno MA, Castaño JP, Luque RM. Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors. Clin Transl Gastroenterol 2018, 9(10):196.
IF: 4.803 Q: 1
Gahete MD, Jimenez-Vacas JM, Alors-Perez E, Herrero-Aguayo V, Fuentes-Fayos AC, Pedraza-Arevalo S, Castano JP, Luque RM; Mouse models of endocrine tumors. J Endocrinol. 2018 Nov 1. pii: JOE-18-0571.R1.
IF: 4,381 Q: 1
Alhambra-Expósito MR, Ibáñez-Costa A, Moreno-Moreno P, Rivero-Cortés E, Vázquez-Borrego MC, Blanco-Acevedo C, Toledano-Delgado Á, Lombardo-Galera MS, Vallejo-Casas JA, Gahete MD, Castaño JP, Gálvez MA, Luque RM. Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas. Sci Rep 2018, 8(1):6173.
IF: 4.011 Q: 1
Venegas-Moreno E, Vazquez-Borrego MC, Dios E, Gros-Herguido N, Flores-Martinez A, Rivero-Cortes E, Madrazo-Atutxa A, Japon MA, Luque RM, Castano JP, Cano DA, Soto-Moreno A. Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly. J Cell Mol Med 2018, 22(3)1640-1649.
IF: 4.658 Q: 1
Alves-Coelho MC, Vasquez ML, Wildemberg LE, Vazquez-Borrego MC, Bitana L, Camacho AHD, Silva D, Ogino LL, Ventura N, Chimelli L, Luque RM, Kasuki L, Gadelha MR. Molecular evidence and clinical importance of beta-arrestins expression in patients with a cromegaly. J Cell Mol Med 2018, 22(4)2110-2116.
IF: 4.658 Q: 1
Herrera-Martínez AD, Gahete MD, Pedraza-Arévalo S, Sánchez-Sánchez R, Ortega-Salas R, Serrano-Blanch R, Luque RM, Gálvez-Moreno MA, Castaño JP. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors. Endocrine 2018, 59(2):426-437.
IF: 3.296 Q: 2
Vázquez-Borrego MC, Gahete MD, Martínez-Fuentes AJ, Fuentes-Fayos AC, Castaño JP, Kineman RD, Luque RM. Review. Multiple signaling pathways convey central and peripheral signals to regulate pituitary function: lessons from human and non-human primate models. Mol Cell Endocrinol 2018, 463:4-22.
IF: 3.693 Q: 2
Rincón-Fernández D, Culler MD, Tsomaia N, Moreno-Bueno G, Luque RM, Gahete MD, Castaño JP. In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines. Carcinogenesis 2018, 39(3):447-457.
IF: 4.004 Q: 2
Luque RM, Kineman RD. Neuronostatin exerts actions on pituitary that are unique from its sibling peptide somatostatin. J Endocrinol 2018, 237(3):217-227.
IF: 4.381 Q: 1
Pedraza-Arevalo S, Gahete MD, Alors-Perez E, Luque RM, CastanoJP. Multilayered heterogeneity as an intrinsic hallmark of neuroendocrinetumors. Rev Endocr Metab Disord 2018, 19(2)179-192.
IF: 5. 516 Q: 1
Jimenez-Lucena R, Camargo A, Alcala-Diaz JF, Romero-Baldonado C, Luque RM, van Ommen B, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Rangel-Zuniga OA, Lopez-Miranda J. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp Mol Med 2018, 50(12):168.
IF: 4.743 Q: 1
Leon-Gonzalez AJ, Navarro I, Acero N, Mingarro DM, Martin-Cordero C. Genus Retama: a review on traditional uses, phytochemistry, and pharmacological activities. Phytochem Rew 2018, 17(4)701-731.
IF: 4.257 Q: 1 D: 1
Gomez-Gomez E, Rosa JV, Valiente JC, Tarradas FT, Curado FA, Ruiz DL, Tapia MJ. New Approach to Guide Target Prostate Biopsy: Technique and Initial Experience. Urology 2018, 121()198-199.
IF: 1.861 Q: 2
Cordoba-Chacon J, Sarmento-Cabral A, del Rio-Moreno M, Diaz-Ruiz A, Subbaiah PV, KinemanRD. Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction. Endocrinology 2018, 159(11)3761-3774.
IF: 3.800 Q: 2
Salamanca-Bustos JJ, Gomez-Gomez E, Campos-Hernandez JP, Carrasco-Valiente J, Ruiz-Garcia J, Marquez-Lopez FJ, Zurera-Tendero L, Requena-Tapia MJ. Initial Experience in the Use of Novel Auto-expandable Metal Ureteral Stent in the Treatment of Ureter Stenosis in Kidney Transplanted Patients. Transplantation Proceedings 2018, 50(2)587-590.
IF: 0.959 Q: 4
Publications in 2017
Hormaechea-Agulla D, Gahete MD, Jimenez-Vacas JM, Gomez-Gomez E, Ibanez-Costa A, L-Lopez F, Rivero-Cortes E, Sarmento-Cabral A, Valero-Rosa J, Carrasco-Valiente J, Sanchez-Sanchez R, Ortega-Salas R, Moreno MM, Tsomaia N, Swanson SM, Culler MD, Requena MJ, Castaño JP, Luque RM. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. MOLECULAR CANCER. 2017. 16(1):146.
IF: 6,204 Q: 1
Hormaechea-Agulla D, Jimenez-Vacas JM, Gomez-Gomez E, Lopez FL, Carrasco-Valiente J, Valero-Rosa J, Moreno MM, Sanchez-Sanchez R, Ortega-Salas R, Gracia-Navarro F, Culler MD, Ibanez-Costa A, Gahete MD, Requena MJ, Castaño JP, Luque RM. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer. FASEB JOURNAL. 2017. 31(11): 4682-4696.
IF: 5,498 Q: 1 D: 1
Luque RM, Lopez-Sanchez LM, Villa-Osaba A, Luque IM, Santos-Romero AL, Yubero-Serrano EM, Cara-Garcia M, Alvarez-Benito M, Lopez-Miranda J, Gahete MD, Castaño JP. Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients. ONCOTARGET. 2017. 8(46):81462-81474.
IF: 5,168 Q: 1
Sarmento-Cabral A, L-Lopez F, Gahete MD, Castaño JP, Luque RM. Metformin reduces prostate tumor growth, in a diet-dependent manner, by modulating multiple signaling Pathways. MOLECULAR CANCER RESEARCH. 2017. 15(7):862-874.
IF: 4,974 Q: 1
L-Lopez F, Sarmento-Cabral A, Herrero-Aguayo V, Gahete MD, Castaño JP, Luque RM. Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2017. 21(9):1893-1904.
IF: 4,499 Q: 1
Herrera-Martinez AD, Gahete MD, Sanchez-Sanchez R, Salas RO, Serrano-Blanch R, Salvatierra A, Hofland LJ, Luque RM, Galvez-Moreno MA, Castaño JP. The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features. LUNG CANCER. 2017. 109:128-136.
IF: 4,294 Q: 1
Sarmento-Cabral A, L-Lopez F, Luque RM. Adipokines and their receptors are widely expressed and distinctly regulated by the metabolic environment in the prostate of male mice: Direct role under normal and tumoral conditions. ENDOCRINOLOGY. 2017. 158(10):3540-3552.
IF: 4,283 Q: 1
Ibanez-Costa A, Lopez-Sanchez LM, Gahete MD, Rivero-Cortes E, Vazquez-Borrego MC, Galvez MA, de la Riva A, Venegas-Moreno E, Jimenez-Reina L, Moreno-Carazo A, Tinahones FJ, Maraver-Selfa S, Japon MA, Garcia-Arnes JA, Soto-Moreno A, Webb SM, Kineman RD, Culler MD, Castaño JP, Luque RM. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas. SCIENTIFIC REPORTS. 2017. 7():42002.
IF: 4,259 Q: 1
Sarmento-Cabral A, Peinado JR, Halliday LC, Malagón MM, Castaño JP, Kineman RD, Luque RM. Adipokines (Leptin, Adiponectin, Resistin) differentially regulate all hormonal cell types in primary anterior pituitary cell cultures from two primate species. SCIENTIFIC REPORTS. 2017. 7:43537.
IF: 4,259 Q: 1
Pedraza-Arévalo S, Hormaechea-Agulla D, Gomez-Gomez E, Requena MJ, Selth LA, Gahete MD, Castaño JP, Luque RM. Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer. PROSTATE. 2017. 77(15):1499-1511.
IF: 3,82 Q: 1
Ibanez-Costa A, Luque RM, Castaño JP. Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism. GROWTH HORMONE & IGF RESEARCH. 2017. 33:23-27.
IF: 1,828 Q: 4
